HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of hypoglycaemia episodes in people with type-2 diabetes fasting in Ramazan, treated with vildaglipton or sulphonylurea: results of the Pakistani cohort of the VIRTUE study.

AbstractOBJECTIVE:
To assess the effect of vildagliptin in comparison to sulphonylurea (SU) on hypoglycaemia in Muslim patients with type 2 diabetes mellitus fasting during Ramadan.
METHODS:
VIRTUE was a multicenter, prospective, observational study, which enrolled 244 patients from Pakistan who were re-analysed. All included patients were treated with vildagliptin (n=121) or SU (n=121) as add-on to metformin or as monotherapy for 16 weeks. The primary outcome of interest was to compare the proportion of patients with ≥1 hypoglycaemic event (HE) during fasting between vildagliptin and SU cohort. Changes in HbA1c and body weight and treatment adherence were also measured.
RESULTS:
Of the 244 patients enrolled, 120 patients in the vildagliptin cohort (99.2%) and 119 patients in the SU cohort (98.3%) completed the study. Patients experiencing at least one HE were fewer with vildagliptin when compared with SUs (5.8% vs. 14.2%; p<0.033). The reduction in HbA1c was 0.3% with vildagliptin from a baseline of 7.6% and 0.1% with SU from a baseline of 7.4% (between-treatment difference: -0.1% p<0.054). A reduction of 0.3 kg was seen with vildagliptin treatment vs. 0.2 kg weight gain in the SU group. Adverse events were experienced by 15.7% in the vildagliptin cohort and 17.4% in the SU group.
CONCLUSION:
The treatment with vildagliptin was associated with fewer hypoglycaemic events compared with SUs and was well tolerated with good glycaemic and weight control in patients with T2DM fasting during Ramadan.
AuthorsSaeed Ahmed Mahar, Mohammad Imtiaz Hasan, Mohammad Imran Hasan Khan, Asher Fawwad, Shakir Hussain, Neeta Maheshwary, Kishore Kumar, Ahson Siddiqi, Muhammad Athar Khan
JournalJPMA. The Journal of the Pakistan Medical Association (J Pak Med Assoc) Vol. 64 Issue 11 Pg. 1297-302 (Nov 2014) ISSN: 0030-9982 [Print] Pakistan
PMID25831650 (Publication Type: Comparative Study, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
Chemical References
  • Hypoglycemic Agents
  • Nitriles
  • Pyrrolidines
  • Sulfonylurea Compounds
  • Vildagliptin
  • Adamantane
Topics
  • Adamantane (analogs & derivatives, therapeutic use)
  • Adult
  • Aged
  • Cohort Studies
  • Diabetes Mellitus, Type 2 (complications, drug therapy, ethnology)
  • Fasting
  • Female
  • Humans
  • Hypoglycemia (epidemiology)
  • Hypoglycemic Agents (therapeutic use)
  • Islam
  • Male
  • Middle Aged
  • Nitriles (therapeutic use)
  • Pakistan
  • Pyrrolidines (therapeutic use)
  • Sulfonylurea Compounds (therapeutic use)
  • Vildagliptin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: